NeuroX1

NeuroX1 is a computational biology company designing new small molecules therapeutics for Central Nervous System (CNS) diseases.  The company leverages AI, quantum computing and genomic data to uncover novel drug targets and optimize the design of small molecules that can pass the blood brain barrier.   The company is partnered with Illumina.